The Duke Prostate Center is on the forefront of prostate cancer research and treatment. See news articles featuring the Duke Prostate Center.
Doctors should discuss financial concerns of cancer patients (DukeHealth.org)
May 16, 2013
Most cancer patients would like to talk about the cost of their care with their doctors, but often don't because they fear the discussion could compromise the quality of their treatment, researchers at Duke Cancer Institute report.
Cancer studies often lack necessary rigor to answer key questions (DukeHealth.org)
Apr. 29, 2013
Fueled in part by an inclination to speed new treatments to patients, research studies for cancer therapies tend to be smaller and less robust than for other diseases.
Immortality gene mutation identifies brain tumors and other cancers (DukeHealth.org)
Mar. 18, 2013
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
Less Invasive Treatment is Associated with Improved Survival in Early Stage Breast Cancer (DukeHealth.org)
Jan. 28, 2013
Patients with early stage breast cancer who are treated with lumpectomy plus radiation have a better chance of survival compared with those who undergo mastectomy, according to Duke Medicine research.
Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
Cholesterol-lowering drugs may slow benign prostate growth (DukeHealth.org)
May 21, 2012
Statins drugs prescribed to treat high cholesterol may also work to slow benign prostate growth in men who have elevated PSA levels, according to an analysis led by researchers at Duke University Medical Center.
Experts Identify Critical Genes Mutated in Stomach Cancer (DukeHealth.org)
Apr. 9, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
New Technology Helps Doctors Better Diagnose, Treat Prostate Cancer (wral.com)
Apr. 3, 2012
Called parametric MRI, the new type of MRI imaging provides more detailed information that can make treatment decisions simpler, including 3D models that give doctors a clearer picture of growing tumors.
Genetic Variation in East Asians Found to Explain Resistance to Cancer Drugs (DukeHealth.org)
Mar. 18, 2012
A multi-national research team led by scientists at Duke-NUS Graduate Medical School has identified the reason why some patients fail to respond to some of the most successful cancer drugs.
Discovery Could Reduce Chemotherapy's Side Effects (DukeHealth.org)
Mar. 11, 2012
A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.
Contact Us
|
Careers
|
Make a Gift
|
Site Map
